SPS
HCAT icon

Susquehanna Portfolio Strategies’s Health Catalyst HCAT Stock Holding History

Susquehanna Portfolio Strategies’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$164K Sell
129,052
-5,181
-4% -$9.75K ﹤0.01% 916
2025
Q4 		$321K Sell
134,233
-96,112
-42% -$263K 0.01% 868
2025
Q3 		$656K Buy
+230,345
New +$788K 0.01% 762

Other funds holding HCAT

FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
CF
CDC Financial Chicago, Illinois $157M AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WCA
Whetstone Capital Advisors Shawnee Mission, Kansas $288M AUM 44.06% 1-Year Est. Return
PVM
Palogic Value Management Dallas, Texas $237M AUM 5.37% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $14.3B AUM 19.8% 1-Year Est. Return
NI
Nepsis Inc Minneapolis, Minnesota $295M AUM 35.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Susquehanna Portfolio Strategies's HCAT Position: Q1 2026 in Review

Susquehanna Portfolio Strategies reduced its Health Catalyst (HCAT) stake by 3.9% in Q1 2026, selling an estimated $9.75K and leaving 129,052 shares worth $164K. The position accounts for ﹤0.01% of the portfolio, ranked #916.

Susquehanna Portfolio Strategies first reported a position in HCAT in Q3 2025 and has held it in 3 quarters since. The position peaked at $656K in Q3 2025. 130 funds tracked by Wall St. Rank hold HCAT as of Q1 2026.

  • Susquehanna Portfolio Strategies held 129,052 shares of Health Catalyst worth $164K as of Q1 2026.
  • Susquehanna Portfolio Strategies sold 5,181 Health Catalyst shares in Q1 2026, an estimated $9.75K.
  • Health Catalyst made up ﹤0.01% of Susquehanna Portfolio Strategies's portfolio in Q1 2026, its #916 holding.
  • Susquehanna Portfolio Strategies first reported a position in Health Catalyst in Q3 2025 and has held it in 3 quarters since.
  • Susquehanna Portfolio Strategies's Health Catalyst position peaked at $656K in Q3 2025.
  • 130 funds tracked by Wall St. Rank held Health Catalyst as of Q1 2026.

Based on Susquehanna Portfolio Strategies's 13F filing for Q1 2026, filed 15 May 2026.